Contemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities
- 547 Downloads
As the older adult segment of the population increases, Alzheimer’s disease (AD) has emerged as a significant public health epidemic. Over the past 3 decades, advances in the understanding of the biology of AD have led to a somewhat unified hypothesis of disease pathogenesis that emphasizes the precipitating role of beta amyloid protein. However, several lines of evidence suggest that multiple pathologies are necessary for clinical manifestation of the disease. Our focus over the past several years has been on the contribution of small vessel cerebrovascular disease, visualized as white matter hyperintensities (WMH) on magnetic resonance imaging, to AD. White matter hyperintensity volume, particularly in parietal regions, is elevated among individuals with and at risk for AD, predicts future diagnosis of AD, predicts the rate of progression of cognitive symptoms among individuals with AD, and increases over time among individuals destined to develop AD. White matter hyperintensities may represent an independent source of impairment and/or may interact more fundamentally with “primary” AD pathology. Future work should focus on more inclusive models of that better define “normal” vs “pathological” aging.
KeywordsAlzheimer’s disease White matter hyperintensities Cerebrovascular disease
Work presented here was supported in part by grants from the National Institutes of Health (AG034189, AG037212, AG028786, AG029949, AG024708), Alzheimer’s Association, Mary E. Groff Surgical Medical Research and Education Charitable Trust, and Columbia University.
Compliance with Ethics Guidelines
Conflict of Interest
Adam M. Brickman has received travel/accommodations expenses covered or reimbursed from the International Neuropsychological Society (as a board member) and the Alzheimer's Association.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.• Jack Jr CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9:119–28. This paper presents a comprehensive hypothesis regarding the cascade of biological events that contribute to the pathogensis of AD.PubMedCrossRefGoogle Scholar
- 2.• Jack Jr CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–16. This paper is an updated version of a pathogenic model for Alzheimer’s disease.PubMedCrossRefGoogle Scholar
- 3.Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2010;7:280–92.CrossRefGoogle Scholar
- 4.Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2010;7:270–9.CrossRefGoogle Scholar
- 6.McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2010;7:263–9.CrossRefGoogle Scholar
- 39.Kertesz A, Black SE, Tokar G, Benke T, Carr T, Nicholson L. Periventricular and subcortical hyperintensities on magnetic resonance imaging. Rims, caps, and unidentified bright objects. Arch Neurol. 1988;45:404–8. Arch Neurol. 1988;45:404–8.Google Scholar
- 49.Brickman AM, Muraskin J, Zimmerman ME. Structural neuroimaging in Alzheimer’s disease: do white matter hyperintensities matter? Dialog Clin Neurosci. 2009;11:181–90.Google Scholar
- 53.Admiraal-Behloul F, Olofesen H, Van den Heuvel DM, Schmitz N, Reiber JH, Van Buchem MA. Fully automated lobe delineation for regional white matter lesion load quantification in a large scale study. Proc Int Soc Magnet Reson Med. 2004:138.Google Scholar
- 54.• Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, et al. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol. 2013;18:1–7. In this paper we showed that both WMH and amyloid are associated with Alzheimer’s disease and that among individuals with evidence of cerebral amyloidosis, those with higher WMH burden were more likely to manifest clinical symptoms.Google Scholar
- 55.Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM. Plasma beta-amyloid an white matter lesions in AD, CI, and cerebral amyloid angiopathy. Neurology. 2006;66:23–9.Google Scholar
- 62.Brickman AM, Provenzano FA, Muraskin J, Guzman VA, Manly JJ, Schupf N, et al. Distribution of MRI-defined white matter hyperintensities in mild cognitive impairment [abstract]. J Int Neuropsychol Soc. 2011;17(S1).Google Scholar
- 64.Meier IB, Manly JJ, Provenzano FA, Hector J, Wasserman BT, Louie K, et al. White matter predictors of cogntiive functioning in older adults. Annual meeting of the International Neuropsychological Society; February, 2011; Boston, MA 2011.Google Scholar
- 73.Wiegman AF, Meier IB, Provenzano FA, Schupf N, Manly JJ, Stern Y, et al. Regional white matter hyperintensity volume and cognition predict death in a multi-ethnic, community cohoort of older adults. J Am Geriatr Soc. 2013.Google Scholar
- 74.Brickman AM, Zarhodne LB, Guzman VA, Narkhede A, Provenzano FA, Schupf N, et al. Reconsidering harbingers of Alzheimer’s disease: regionally distributed progression of white matter hyperintensities in the community. [In preparation].Google Scholar
- 81.Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke. 2008;39:1127–33.Google Scholar
- 82.Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebral auotregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol. 2002;283:H315–23.Google Scholar
- 93.Meier IB, Narkhede A, Provenzano FA, Luchsinger JA, Manly JJ, Willey JZ, et al. Lobar microbleeds are associated with white matter hyperintensities and memory in older adults [abstract]. J Int Neuropsychol Soc. 2012;18:224–5.Google Scholar
- 94.Guzman VA, Carmichael OT, Schwarz C, Tosto G, Zimmerman ME, Brickman AM, et al. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume. Alzheimer’s and Dementia. 2013;9:S124–31.Google Scholar
- 96.Provenzano FA, Cortes ER, Dashnaw S, Brickman AM. Neuroimaging-guided pathological examination of white matter hyperintensities in aging. Annual Meeting of the International Neuropsychological Society; February, 2011; Boston, MA. 2011.Google Scholar